Results 71 to 80 of about 13,337 (185)

Hyperandrogen-induced imbalance of FOXO4-AR regulatory loop contributes to ovulatory disorders in polycystic ovary syndrome

Molecular Therapy: Nucleic Acids
Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility, and its underlying mechanisms remain largely unknown. Our study aimed to investigate the role of FOXO4 in PCOS and its possible regulatory mechanisms.
Ruiqiong Zhou, Zhaoyi Wang, Mei Dong, Songlu Wang, Xiangyuan Li, Junjiu Huang, Xiqian Zhang, Fenghua Liu   +7 more
doaj   +1 more source

Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome

Endocrinology, Diabetes & Metabolism
Context Hyperandrogenism is a hallmark of polycystic ovary syndrome (PCOS), yet the androgen(s) responsible remain ambiguous. Recent studies have suggested that 11‐oxygenated C19 steroids (11‐oxyandrogens), specifically 11‐ketotestosterone, may be a good
Armaiti Parvez Mody, Maya Beth Lodish, Richard Joseph Auchus, Adina F. Turcu, Fei Jiang, Heather Gibson Huddleston   +5 more
doaj   +1 more source

Bilateral ovarian steroid cell tumor in a postmenopausal woman with progressive hyperandrogenism. [PDF]

JCEM Case Rep
Tapia Sanchiz MS, Justel Enríquez A, Álvarez RM, Sebastian-Valles F, Marazuela M.   +4 more
europepmc   +1 more source

Case Report: Postmenopausal hyperandrogenism misled by adrenal incidentaloma: a rare case of androgen-secreting ovarian adult granulosa cell tumor and clinical implications. [PDF]

Front Oncol
Cao C, Wang X.
europepmc   +1 more source

Obesity and female reproductive health in Asian population. [PDF]

Obes Pillars
Panyakhamlerd K, Sophonsritsuk A, Pantasri T, Suwan A, Panyawongudom N, Samakkarnthai P.   +5 more
europepmc   +1 more source

Evaluation of muscle strength assessment in adolescent polycystic ovary syndrome: a case control study. [PDF]

BMC Womens Health
Sacinti HG, Ibanoglu MC, Celik GE, Sanisoglu Y, Ustun YE.   +4 more
europepmc   +1 more source

Efficacy evaluation of ultrasound-derived fat fraction in predicting of the severity of women with polycystic ovary syndrome and obesity. [PDF]

Front Med (Lausanne)
Meng L, Wang J, Liu W, Qin Y, Yang Z, Xu Y.   +5 more
europepmc   +1 more source

PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review

Drug Design, Development and Therapy
Guglielmo Lentini, Alessandro Querqui, Noemi Monti, Mariano Bizzarri Department of Experimental Medicine, Space Biomedicine Laboratory, University Sapienza, Rome, ItalyCorrespondence: Mariano Bizzarri, Email mariano.bizzarri@uniroma1.itIntroduction: This
Lentini G, Querqui A, Monti N, Bizzarri M   +3 more
doaj  

Comparative analysis of hormonal and metabolic indices in phenotypic subgroups of polycystic ovary syndrome. [PDF]

J Turk Ger Gynecol Assoc
Savran Üçok B, Dikici Aktaş T, Özalp E, Ulusoy CO, Akbulut ÖV, Kından A, Fıratlıgil FB.   +6 more
europepmc   +1 more source

Ovarian Hyperandrogenism [PDF]

, 2020
openaire   +1 more source